Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Long-Term Debt Repayments: 2020-2022

Historic Long-Term Debt Repayments for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Sep 2022 value amounting to $575,000.

  • Insight Molecular Diagnostics' Long-Term Debt Repayments rose 53.33% to $575,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $1.7 million, marking a year-over-year increase of 23.64%. This contributed to the annual value of $1.3 million for FY2022, which is 11.67% down from last year.
  • As of Q3 2022, Insight Molecular Diagnostics' Long-Term Debt Repayments stood at $575,000, which was up 53.33% from $375,000 recorded in Q2 2022.
  • Insight Molecular Diagnostics' 5-year Long-Term Debt Repayments high stood at $575,000 for Q3 2022, and its period low was $250,000 during Q4 2020.
  • Its 3-year average for Long-Term Debt Repayments is $384,375, with a median of $375,000 in 2022.
  • Data for Insight Molecular Diagnostics' Long-Term Debt Repayments shows a peak YoY skyrocketed of 53.33% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Insight Molecular Diagnostics' Long-Term Debt Repayments stood at $250,000 in 2020, then surged by 50.00% to $375,000 in 2021, then soared by 53.33% to $575,000 in 2022.
  • Its last three reported values are $575,000 in Q3 2022, $375,000 for Q2 2022, and $375,000 during Q1 2022.